Publication Name	World Journal of Gastroenterology
Manuscript ID	6009
Country	Türkiye

Received	2013-09-29 18:02
Peer-Review Started	2013-09-30 14:38
To Make the First Decision	2013-10-22 16:06
Return for Revision	2013-10-28 12:08
Revised	2013-11-15 03:38
Second Decision	2014-01-06 18:19
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-01-06 19:00
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-03-12 13:37
Typeset the Manuscript	2014-04-17 09:19
Publish the Manuscript Online	2014-05-14 10:58

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Helicobacter pylori: Management in 2013
Manuscript Source	Invited Manuscript
All Author List	Yesim Ozen Alahdab and Cem Kalayci
Funding Agency and Grant Number
Corresponding Author	Yesim Ozen Alahdab, MD, Department of Gastroenterology and Hepatology, Fatih Sultan Mehmet Education and Research Hospital, E5 Karayolu Uzeri Icerenkoy-Atasehir, 34752 Istanbul, Turkey. yesimalahdab@yahoo.com
Key Words	Helicobacter pylori; First-line therapy; Second-line therapy; Rescue therapy
Core Tip	Helicobacter pylori (H. pylori) is a prevalent, worldwide, chronic infection. The ideal therapy regimen for H. pylori infection should achieve an eradication rate ≥ 80%. Triple therapy remains an appropriate first-line therapy in areas of low clarithromycin resistance, and quadruple therapy should be the first-line therapy in areas of high clarithromycin resistance. Sequential therapy can be an alternative. Levofloxacin-containing regimens or concomitant therapies can be good choices for second-line therapy. Choice of treatment regimen for H. pylori infection should be done cautiously and antibiotic-resistance rates should be taken into consideration.
Publish Date	2014-05-14 10:58
Citation	Alahdab YO, Kalayci C. Helicobacter pylori: Management in 2013. World J Gastroenterol 2014; 20(18): 5302-5307
URL	http://www.wjgnet.com/1007-9327/full/v20/i18/5302.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i18.5302

Full Article (PDF)	WJG-20-5302.pdf
Full Article (Word)	WJG-20-5302.doc
Manuscript File	6009-Review.doc
Answering Reviewers	6009-Answering reviewers.pdf
Copyright License Agreement	6009-Copyright assignment.pdf
Peer-review Report	6009-Peer reviewer(s).pdf
Scientific Editor Work List	6009-Scientific editor work list.doc